Shariati A, Ebrahimi T, Babadinia P, Shariati F, Cohan R
Sci Rep. 2023; 13(1):4520.
PMID: 36934115
PMC: 10024681.
DOI: 10.1038/s41598-023-31252-0.
Ray S, Li Z, Hsu C, Hwang L, Lin Y, Chou P
Theranostics. 2019; 8(22):6322-6349.
PMID: 30613300
PMC: 6299700.
DOI: 10.7150/thno.27828.
Arms L, Smith D, Flynn J, Palmer W, Martin A, Woldu A
Front Pharmacol. 2018; 9:802.
PMID: 30154715
PMC: 6102329.
DOI: 10.3389/fphar.2018.00802.
Liu X, Madhankumar A, Miller P, Duck K, Hafenstein S, Rizk E
Neuro Oncol. 2015; 18(5):691-9.
PMID: 26519740
PMC: 4827043.
DOI: 10.1093/neuonc/nov263.
Jackson A, Chandrasekharan P, Shi J, Rannard S, Liu Q, Yang C
Int J Nanomedicine. 2015; 10:5895-907.
PMID: 26425088
PMC: 4583124.
DOI: 10.2147/IJN.S88764.
Convertible MRI contrast: Sensing the delivery and release of anti-glioma nano-drugs.
Zhang L, Zhang Z, Mason R, Sarkaria J, Zhao D
Sci Rep. 2015; 5:9874.
PMID: 25962872
PMC: 4428068.
DOI: 10.1038/srep09874.
Preparation and Evaluation of Multiple Nanoemulsions Containing Gadolinium (III) Chelate as a Potential Magnetic Resonance Imaging (MRI) Contrast Agent.
Sigward E, Corvis Y, Doan B, Kindsiko K, Seguin J, Scherman D
Pharm Res. 2015; 32(9):2983-94.
PMID: 25805598
DOI: 10.1007/s11095-015-1680-8.
Stabilized porous liposomes with encapsulated Gd-labeled dextran as a highly efficient MRI contrast agent.
Cheng Z, Al Zaki A, Jones I, Hall Jr H, Aspinwall C, Tsourkas A
Chem Commun (Camb). 2014; 50(19):2502-4.
PMID: 24457826
PMC: 3947407.
DOI: 10.1039/c3cc48939f.
Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening.
Bruckman M, Yu X, Steinmetz N
Nanotechnology. 2013; 24(46):462001.
PMID: 24158750
PMC: 3895399.
DOI: 10.1088/0957-4484/24/46/462001.
Gd-based macromolecules and nanoparticles as magnetic resonance contrast agents for molecular imaging.
Huang C, Tsourkas A
Curr Top Med Chem. 2013; 13(4):411-21.
PMID: 23432004
PMC: 3761358.
DOI: 10.2174/1568026611313040002.
Porous Polymersomes with Encapsulated Gd-labeled Dendrimers as Highly Efficient MRI Contrast Agents.
Cheng Z, Thorek D, Tsourkas A
Adv Funct Mater. 2013; 19(23):3753-3759.
PMID: 23293575
PMC: 3536029.
DOI: 10.1002/adfm.200901253.
Gadolinium-based contrast agents for magnetic resonance cancer imaging.
Zhou Z, Lu Z
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012; 5(1):1-18.
PMID: 23047730
PMC: 3552562.
DOI: 10.1002/wnan.1198.
Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound.
Negussie A, Yarmolenko P, Partanen A, Ranjan A, Jacobs G, Woods D
Int J Hyperthermia. 2011; 27(2):140-55.
PMID: 21314334
PMC: 3417228.
DOI: 10.3109/02656736.2010.528140.
A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity.
Chen K, Wolahan S, Wang H, Hsu C, Chang H, Durazo A
Biomaterials. 2010; 32(8):2160-5.
PMID: 21167594
PMC: 3032383.
DOI: 10.1016/j.biomaterials.2010.11.043.
Paramagnetic liposome nanoparticles for cellular and tumour imaging.
Kamaly N, Miller A
Int J Mol Sci. 2010; 11(4):1759-76.
PMID: 20480040
PMC: 2871136.
DOI: 10.3390/ijms11041759.
Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis.
Strijkers G, Kluza E, van Tilborg G, van der Schaft D, Griffioen A, Mulder W
Angiogenesis. 2010; 13(2):161-73.
PMID: 20390447
PMC: 2911540.
DOI: 10.1007/s10456-010-9165-1.
Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.
Villaraza A, Bumb A, Brechbiel M
Chem Rev. 2010; 110(5):2921-59.
PMID: 20067234
PMC: 2868950.
DOI: 10.1021/cr900232t.
New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.
Ghaghada K, Ravoori M, Sabapathy D, Bankson J, Kundra V, Annapragada A
PLoS One. 2009; 4(10):e7628.
PMID: 19893616
PMC: 2764087.
DOI: 10.1371/journal.pone.0007628.
Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.
Torchilin V
Eur J Pharm Biopharm. 2008; 71(3):431-44.
PMID: 18977297
PMC: 3197821.
DOI: 10.1016/j.ejpb.2008.09.026.
T1 relaxivity of core-encapsulated gadolinium liposomal contrast agents--effect of liposome size and internal gadolinium concentration.
Ghaghada K, Hawley C, Kawaji K, Annapragada A, Mukundan Jr S
Acad Radiol. 2008; 15(10):1259-63.
PMID: 18790397
PMC: 2746039.
DOI: 10.1016/j.acra.2008.04.018.